Proteomic Aging Clocks Enter the Clinic in Landmark Phase 2a Geroprotection Trial
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
A new review in Molecular Cancer redefines the abscopal effect with strict diagnostic criteria and maps the immunological steps needed ...
In an exciting development that aligns traditional Eastern medicine with modern clinical approaches, a new study has emerged targeting a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine